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Nonhuman primates (NHP) are particularly important for modeling infections with viruses
that do not naturally replicate in rodent cells. Zika virus (ZIKV) has been responsible for
sporadic epidemics, but in 2015 a disseminated outbreak of ZIKV resulted in the World
Health Organization declaring it a global health emergency. Since the advent of this last
epidemic, several NHP species, including the baboon, have been utilized for modeling and
understanding the complications of ZIKV infection in humans; several health issues related
to the outcome of infection have not been resolved yet and require further investigation.
This study was designed to validate, in baboons, the molecular signatures that have
previously been identiﬁed in ZIKV-infected humans and macaque models. We performed
a comprehensive molecular analysis of baboons during acute ZIKV infection, including
ﬂow cytometry, cytokine, immunological, and transcriptomic analyses. We show here
that, similar to most human cases, ZIKV infection of male baboons tends to be subclinical,
but is associated with a rapid and transient antiviral interferon-based response signature
that induces a detectable humoral and cell-mediated immune response. This immunity
against the virus protects animals from challenge with a divergent ZIKV strain, as
evidenced by undetectable viremia but clear anamnestic responses. These results
provide additional support for the use of baboons as an alternative animal model to
macaques and validate omic techniques that could help identify the molecular basis of
complications associated with ZIKV infections in humans.
Keywords: transcriptomic, immunology and infectious diseases, cytokines, nonhuman primate (NHP), arboviral diseases
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(Peregrine et al., 2019), and transmission of ZIKV infection to
female baboons after exposure to ZIKV-infected baboon semen
(Gurung et al., 2020). In this study, we validate the baboon model
with the use of molecular and immunological tools. We show
that the acutely infected baboon, even in the absence of
noticeable clinical signs, presents molecular signatures of
antiviral responses similar to the ones observed in ZIKVinfected humans. This weak immune response is enough to
protect animals against a re-challenge with a divergent ZIKV.

INTRODUCTION
Zika virus (ZIKV), a positive sense single-stranded RNA virus,
belongs to the Flaviviridae family, which includes other viruses
such as the yellow fever, dengue, and West Nile viruses. ZIKV
was initially discovered in the serum of a febrile sentinel Rhesus
macaque monkey in the Zika forest of Uganda in 1947. During
the 2013 ZIKV epidemic in the French Polynesia, an increased
incidence of Guillain-Barré syndrome (GBS) was observed in
adults, and an increased incidence of microcephaly and
brainstem dysfunction was observed in fetuses and newborns
(Saiz et al., 2017). Despite this, research on ZIKV remained
relatively neglected up until the 2015 Brazil outbreak, which
exhibited similar increases in GBS and neurological
complications in fetuses and newborns (Wikan and Smith,
2016; Bradley and Nagamine, 2017; Saiz et al., 2017; Dong and
Liang, 2018). Consequently, in February of 2016, the World
Health Organization declared ZIKV a global health emergency
(Dong and Liang, 2018). As clear from the current COVID-19
pandemic and frequent episodes of ﬂu and Ebola virus
epidemics, viral diseases represent the most immediate
infectious disease threat to global human health. In that
context, reliable animal models remain critical for
understanding pathogenesis of viral infection and for the
development of vaccines and therapeutic approaches to limit
their impact in human populations. Based on close similarities in
genomic organization, physiology, and susceptibility to viral
infections, nonhuman primate (NHP) models are recognized
as the most translational animal models (Estes et al., 2018).
Different NHP models have been developed to address issues
such as ZIKV pathogenesis and vaccine development. Asian
macaque species, including rhesus macaques [Macaca mulatta,
(Dudley et al., 2016; Li et al., 2016; Osuna et al., 2016; Carroll
et al., 2017)], cynomolgus macaques [M. fascicularis, (Koide
et al., 2016; Osuna et al., 2016)], and pig-tailed macaques [M.
nemestrina, (Adams Waldorf et al., 2016)], were the ﬁrst
nonhuman species used for modeling ZIKV infections. Other
models included a New World primate species such as the
marmoset [Callithrix jacchus, (Chiu et al., 2017)], and African
species such the African green monkey [Chlorocebus sabaeus,
(Haddow et al., 2020)] and the olive baboon [Papio anubis,
(Gurung et al., 2018)], due to their likely role as a zoonotic
reservoir for ZIKV (Buechler et al., 2017).
The olive baboon model of ZIKV infection has an important
translational value, considering that baboons resemble humans
closely with respect to size, genetics (Cox et al., 2013), placenta
formation (Carter, 2007), reproduction (Kyama et al., 2007; Li
et al., 2018), brain development (Banks et al., 2017), immunology
(Attanasio et al., 2002; Giavedoni et al., 2004; Warfel and Merkel,
2014), and potential for stem-cell modiﬁcation (Navara et al.,
2018; Olivier et al., 2019). Previous studies of infection of
baboons with ZIKV have shown similarities of clinical signs
(Gurung et al., 2018), transmission of ZIKV from infected dams
to their fetuses with considerable fetal lesions (Gurung et al.,
2019), transient presence of ZIKV in the semen of infected males
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MATERIALS AND METHODS
Animal Ethics Statement
All animal studies were conducted at the Southwest National
Primate Research Center (SNPRC), Texas Biomedical Research
Institute; molecular, viral, and transcriptome analyses of baboon
body ﬂuids and tissues were conducted at Texas Biomed. Texas
Biomed is accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care (AAALAC)
International and operates in accordance with the NIH and U.S.
Department of Agriculture guidelines and the Animal Welfare
Act. The Institutional Animal Care and Use Committee (IACUC)
and the Institutional Biohazards Committee (IBC) of Texas
Biomed approved all baboon experiments related to this study.
All experiments were performed in accordance with relevant
guidelines and regulations.

Animal Studies
Four juvenile baboons (32535, 32569, 32588, and 32753) were
kept healthy and well-nourished with strict feeding protocols and
close monitoring of their health status prior to the start of the
study and during the entire study period. One week before
inoculation, animals were transferred to the biosafety level
(BSL)-2+ facility at the SNPRC and housed individually in
cages. As they are social animals in the wild, all baboons had
auditory, visual, and olfactory access to each other throughout
the study. At the end of the study, baboons were sedated and
humanely euthanized by administration of a sodium
pentobarbital solution by a licensed veterinarian at the SNPRC.
Baboons were injected with 104 (32569 and 32753) or 106 (32535
and 32588) TCID 50 of the Puerto Rico strain of ZIKV
(PRVABC59, 2015) by the subcutaneous route in the
interscapular region. Six months after primary infection (week
25 post-ZIKV PR2015 challenge), the same animals were
exposed to 104 TCID50 of the Uganda strain of ZIKV (ZIKV
UG1947). ZIKV strains were obtained from the Viral and
Rickettsial Disease Laboratory (VRDL) branch of the
California Department of Public Health and were ampliﬁed by
one additional passage on Vero cells (Chiu et al., 2017). Animals
were sedated at days -7, 0, 1, 3, 6, 9, 13, 15, 17, 21, and 28 after
each viral exposure. Biological samples obtained from
experimental animals consisted of blood, mucosal (oral and
rectal) swabs, and urine; systemic tissues were collected after
necropsy. During each sedation, animals were evaluated for body
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weight, heart and respiratory rate, presence of abdominal skin
rash and conjunctivitis, and measurement of rectal temperature.

10 kDa (IP-10, CXCL10), interleukin-1 beta (IL-1b), IL-1
receptor antagonist (IL-1RA), IL-4, IL-8, IL-10, IL-12 p40 and
p70, IL-15, IL-18, IL-22, monocyte chemoattractant protein 1
(MCP-1, CCL2), macrophage migration inhibitory factor (MIF),
monokine induced by gamma interferon (MIG, CXCL9),
macrophage inﬂammatory protein 1-alpha (MIP-1a, CCL3),
MIP-1b (CCL4), regulated on activation, normal T cell
expressed and secreted (RANTES, CCL5), tumor necrosis
factor-alpha (TNF-a), soluble CD40 ligand (sCD40L), soluble
intercellular adhesion molecule 1 (sICAM-1), and vascular
endothelial growth factor A (VEGF-A).

Measurement of ZIKV RNA Loads by
Quantitative RT-PCR
The course of infection in inoculated animals was monitored by
determination of ZIKV RNA loads (expressed as RNA copies/
mL) in plasma, urine, and mucosal swabs. Estimated ZIKV RNA
loads were calculated by generation of a standard curve, followed
by quantitative RT-PCR testing for 40 cycles using primers
targeting the envelope gene (ZIKV-1086/ZIKV-1162). By
standard curve analysis, the estimated limit of detection for the
qRT-PCR assay is ~15 RNA copies/mL).

ZIKV Serological Analysis by
Antibody Neutralization
Plaque-reduction neutralization testing (PRNT) on longitudinally
collected baboon plasma was performed by the California
Department of Public Health. The protocol was similar to that
used by the US CDC for conﬁrmatory ZIKV testing in patients
(Chiu et al., 2017). Brieﬂy, 100 plaque forming units (PFU) of ZIKV
(1947 Uganda strain or 2015 PR strain, depending on the strain that
was inoculated) were mixed with equal volumes of serial 2-fold
dilutions of inactivated baboon plasma and incubated for 1 hr at 36°
C, followed by addition of this mixture to a monolayer culture of
Vero cells for 1 hr at 36°C. After removal of the inoculum, 3 mL of
2% agar in Eagle’s Minimal Essential Medium (MEM) were added,
plates were placed in a 36°C, 5% CO2 incubator for 3 days, followed
by addition of 3 mL of 1% agar and 0.004% neutral red in Eagle’s
MEM and another 1–2 days of incubation until plaques were
formed. An 80% reduction of the number of plaques compared to
positive control wells inoculated with virus-diluent mixtures was
considered neutralization, with serum titers reported as the highest
dilution exhibiting ≥80% reduction.

Lymphocyte Phenotyping and
Activation State
Phenotypic characterization of baboon peripheral blood
mononuclear cells (PBMCs) was performed by multicolor ﬂow
cytometry using direct immunoﬂuorescence. Aliquots of 100 ml
of EDTA whole blood were directly incubated with antibodies for
20 minutes at room temperature; red blood cells were lysed with
ammonium-chloride-potassium (ACK) buffer, and cells were
then washed twice with phosphate-buffered saline (PBS) and
ﬁxed with 1.6% methanol-free formaldehyde before analysis in a
CyAn ADP ﬂow cytometer (Beckman-Coulter). The antibodies
used for this analysis were conjugated to ﬂuorescein
isothiocyanate (FITC), Phycoerythrin (PE), Peridininchlorophyll-cyanin 5.5 (PerCP-Cy5.5), Phycoerythrin-cyanin
5.1 (PC5), Phycoerythrin-cyanin 7 (PC7), Paciﬁc Blue, BD
Horizon V500, Allophycocyanin (APC) or Alexa Fluor 700.
Antibodies included in this study were: CD3 (clone SP34.2),
CD4 (clone L200), CD154 (clone TRAP-1), and HLA-DR (clone
G46.6/L243) from BD-Biosciences; CD14 [clone 322A-1 (My4),
CD159a (NKG2A; clone Z199), CD20 (clone H299(B1)], CD335
(NKp46; clone BAB281) and CD337 (NKp30; clone Z25) from
Beckman-Coulter; CD16 (clone 3G8), CD8 (clone 3B5), CD40
(clone 5C3), CD83 (clone HB15), and CD86 (clone IT2.2) from
Biolegend; and CD159c (NKG2C;clone 134522) from R&D
Systems. For analyses, lymphocytes were gated based on their
characteristic forward and side scatter pattern, followed by T-cell
selection using a second gate on the CD3-positive population.
Thus, CD8 T cells were deﬁned as CD8+/CD3+ and CD4 T cells
as CD4+/CD3+. Natural Killer cells (NK) were deﬁned as CD3-/
CD20-/CD14- lymphocytes and analyzed by the expression of
NK cell markers CD16, CD8, NKG2A, NKG2C, NKp30 and
NKp46. B cells were deﬁned as CD20+/CD3-/CD14-.

ELISA for ZIKV-Binding Antibodies
ELISA assays for ZIKV-binding antibodies on longitudinally
collected baboon plasma samples were performed with
commercially available kits. Cross-reacting baboon antiDengue Virus envelope IgG antibodies were identiﬁed with the
Dengue Virus Igg Dxselect kit (DiaSorin Molecular, Cat. No.
El1500g), whereas anti-ZIKV NS1 binding IgG antibodies were
detected with the Recombivirus Monkey Anti-Zika Virus NS1
IgG ELISA Kit (Alpha Diagnostic International, Cat. No. RV403310). Binding was expressed as optical density at 450 nm.

ZIKV-Speciﬁc Cell-Mediated Responses
Detection of ZIKV-speciﬁc baboon cell-mediated immune
responses was performed with a modiﬁed indirect T cell
recognition assay (ITRA, (Tong et al., 2014). Brieﬂy, baboon
PBMC were obtained from anticoagulated blood and
resuspended in RPMI with 10% FBS (RPMI-10) at 107 cell/ml.
Aliquots of 100 ml of cell suspension were added to each of three
4-ml polypropylene tubes labeled NEG, POS, and ZIKV. The
NEG tube received 100 ml of supernatant from HEK cells stably
transduced with an empty lentiviral vector. The POS tube
received 100 ml of Staphylococcus enterotoxin A/B at 2 mg/ml
in RPMI-10. The ZIKV tube received 100 ml of supernatant from
HEK cells stably transduced with a lentiviral vector expressing

Multiplex Cytokine Analysis of
Plasma Samples
Plasma samples were analyzed for baboon cytokines and
chemokines on the Luminex 200 system using established
protocols for baboon biomarkers (Reyes et al., 2017; ObregonPerko et al., 2018; Scordo et al., 2021). The assay included
evaluation of the following 25 analytes: B-cell activating factor
(BAFF), growth-related oncogene-a (GRO-a; CXCL1),
interferon alpha (IFN-a), IFN-g, interferon g-induced protein
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the ZIKV prME gene. Cells were incubated for 24 hs at 37°C and
then centrifuged to separate cells and supernatant. Cells were
stained for expression of CD3, CD4, CD8, CD20, CD40, CD83,
and CD154 as detailed in the Lymphocyte Analysis section, while
supernatants were analyzed by Luminex for measurement of the
concentration of CXCL-9/MIG, CXCL10/IP10, CXCL-11/ITAC, IL-2, IL-6, IFN-g, perforin, and TNF-a. Cytokine
production and lymphocyte activation values for ZIKV
activation versus control wells for the four baboons were
analyzed by two-tailed paired t-tests and considered signiﬁcant
if P values were smaller than 0.05.

A second PCA plot was generated excluding data from animal
32535 at day 0, and indicated that animal 32535 was also an
outlier at the other two timepoints included in the RNA-seq data
(days 3 and 15 post-infection) (Supplemental Figure 1B). Due
to these results, all data from animal 32535 were excluded from
downstream analyses.
Data normalization and differential expression (DE) analysis
of gene count data were also performed using the R/
Bioconductor DESeq2 package [version 1.34.0, RRID:
SCR_015687 (Love et al., 2014; RStudio Team, 2018; R Core
Team, 2019)]. Pairwise analyses were conducted to calculate the
fold-change in expression of genes between 3 vs 0 dpi, 15 vs 0 dpi,
and 15 vs 3 dpi.
Gene Set Enrichment Analysis (GSEA) (version 4.2.2, RRID:
SCR_003199) was performed using the hallmark and Reactome
canonical pathways gene sets from the Molecular Signatures
Database (MSigDB) (version 7.5.1). The Database for
Annotation, Visualization, and Integrated Discovery (DAVID)
Functional Annotation tool [2021 Update, RRID: SCR_001881
(Huang et al., 2009a; Huang et al., 2009b)] was used to detect
enriched Biological Process gene ontology (GO) terms. Gene lists
for DAVID GO analyses were generated by ﬁltering DE analysis
results for genes with an FDR ≤ 0.05 and LFC ≥ ± 1.0.

RNA Sequencing

RNA was isolated from PBMCs using the Direct-zol™ RNA
Microprep Kit (Zymo Research), then quantitated by Qubit
ﬂuorometric assay (ThermoFisher Scientiﬁc) and quality
assessed by Agilent Tapestation (Agilent Technologies). 50-100
ng of high-quality RNA per sample was then normalized by
concentration to perform library preparation. The KAPA mRNA
HyperPrep Kit (Roche) was used to construct strand-speciﬁc,
uniquely indexed cDNA libraries for multiplexed sequencing. To
prepare libraries of mRNA transcripts, each RNA sample was
subjected to mRNA capture using magnetic oligo-dT beads,
fragmentation using heat and magnesium, random primed 1st
strand cDNA synthesis, combined 2nd strand cDNA synthesis
and A-tailing, barcode adapter ligation, and library ampliﬁcation
using high-ﬁdelity, low-bias PCR. Agilent Tapestation (Agilent
Technologies) was used to assess cDNA library quality and
fragment size. The number of fragments carrying appropriate
adapter sequences at both ends were quantiﬁed by qPCR on a
QuantStudio 5 Real-Time PCR system (ThermoFisher Scientiﬁc)
using the KAPA Library Quantiﬁcation kit for Illumina
platforms (Roche). Individual libraries were then normalized
by concentration and pooled according to compatible indices
prior to sequencing. Transcripts were sequenced using the
Illumina HiSeq 2500 platform, which also performed primary
analyses of the raw sequence data, including calling, quality
ﬁltering, index de-multiplexing, and adapter trimming. These
primary analyses provided approximately 10 million highquality, 100 bp paired end reads per sample in FASTQ format,
which were then used for secondary data analyses performed
with a pipeline of software tools available from Partek Flow
(Partek Inc.). These secondary analyses included steps such as
additional ﬁltering of reads to base quality of Phred 30, and
alignment of reads to the publicly available assembly of the olive
baboon genome, Panubis 1.0 (Batra et al., 2020), with the RNASeq aligner pipeline STAR 2.5.3a (Dobin et al., 2013), post
alignment quality assessment, and transcript abundance
estimation according to Ensembl transcriptome annotation by
expectation- maximization algorithm.

RESULTS
Virus Dynamics
Baboons were inoculated by the subcutaneous route with two
different doses of the Puerto Rico strain of ZIKV (PRVABC59,
2015), and blood, urine, and mucosal (oral and rectal) swab
samples were collected every 2-3 days during the acute phase of
infection. Animals that received the 106 TCID50 dose became

Transcriptomic Analysis

FIGURE 1 | Plasma ZIKV loads in four olive baboons. The baboons were
initially infected with the Puerto Rico strain of ZIKV (PRVABC59, 2015) via
subcutaneous injection with the virus in either a high dose of 106 TCID50
(n = 2, open symbols) or a low dose of 104 TCID50 (n = 2, closed symbols).
After 25 weeks, the baboons were exposed to 104 TCID50 of the divergent
ZIKV Uganda strain (ZIKV UG1947) through subcutaneous injection.

Principal component analysis (PCA) plots were generated using
the R/Bioconductor package DESeq2 [version 1.34.0, RRID:
SCR_015687 (Love et al., 2014; RStudio Team, 2018; R Core
Team, 2019)], and indicated that one of the four animals (32535)
was an outlier at day 0 post-infection (Supplemental Figure 1A).
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there were no signiﬁcant changes in circulating lymphocyte
subset numbers after ZIKV infection, the activation state of
several cells increased during the acute stage of infection.
Compared to pre-infection levels, the percentage of
lymphocytes expressing the early activation marker CD69
increased immediately after primary infection on NK cells
(Figure 2A) and CD8 T cells (Figure 2B), while it peaked at
about 2 weeks post-infection for CD4 T cells (Figure 2C).
Expression of the CD4 T cell activation marker CD154
(CD40L) also increased after infection and reached a peak of
expression by 4 weeks -post infection; interestingly, there was no
detectable change in the expression of this marker after challenge
with ZIKV UG (Figure 2D). Expression of the activation marker
CD83 on B cells was not consistent for all animals, although
there was a detectable transient increase after the primary
infection with ZIKV PR (Figure 2E). The evaluation of several
NK activating and inhibitory receptors such as CD16, NKG2A,
NKG2C, NKp30, and NKp46 did not result in any consistent and
signiﬁcant pattern in response to ZIKV infection (data not
shown). This ﬂow cytometry analysis suggests that even a
subclinical ZIKV infection can induce detectable transient
systemic changes in the activation state of certain
lymphocyte subset.
Changes in the concentration of plasma cytokines were
determined by Luminex analysis with 25 anti-human cytokine

viremic as early as one day post-infection (dpi), while the
animals receiving the 104 TCID50 had detectable virus by 3 dpi
(Figure 1). Viremia was present in all animals and lasted for
about 5 days. Virus was sporadically present in the urine of some
animals during this viremic period. There were no visible clinical
signs of infection in any of the animals (including weight loss,
body rash, and conjunctivitis), and body temperature was stable
during the viremic phase. After a 25-week period, all animals
were exposed to 104 TCID50 of the divergent ZIKV Uganda
strain (ZIKV UG1947) by the same SQ route. Samples taken
from all animals during this post-challenge period followed a
schedule similar to the one performed during the primary
infection and were below the limit of detection by the same
real time RT-PCR assay, indicating that re-infection was
controlled in these convalescent animals (Figure 1). Back
titration on Vero cells of both ZIKV stocks conﬁrmed the
correct dose of infectious viruses.

Systemic Immune Changes After
ZIKV Infection
Systemic immune changes induced by acute infection and
rechallenge with ZIKV were identiﬁed in blood samples
obtained frequently after ZIKV infection. Changes in
lymphocyte subset numbers and their activation state were
monitored by polychromatic ﬂow cytometry (Figure 2). While

A

B

D

C

E

FIGURE 2 | ZIKV infection in baboons induces a detectable transient systemic change in the activation state of NK, CD8 T, CD4 T, and B cells. The percentage
of (A) NK cells and (B) CD8 T cells expressing CD69 increased immediately after infection with ZIKV PR. (C) The percentage of CD4 T cells expressing CD69
peaked at approximately 2 weeks post-infection. (D) The percentage of CD4 T cells expressing CD154 also increased after infection and peaked at 4 weeks
post-infection. No changes in expression were detected after challenge with ZIKV UG. (E) Expression of CD83 on B cells. Activation markers were detected
using polychromatic ﬂow cytometry. The baboons were challenged with the virus in either a high dose of 106 TCID50 (n = 2, open symbols) or a low dose of 104
TCID50 (n = 2, closed symbols).
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A

B

C

D

E

F

FIGURE 3 | Baboon plasma cytokine levels after ZIKV PR infection. (A) IFN-a, (B) IFN-g, (C) IP-10/CXCL10, (D) BAFF, (E) MIG/CXCL9, and (F) perforin. Cytokines
were measured using Luminex assays. The baboons were challenged with the virus in either a high dose of 106 TCID50 (n = 2, open symbols) or a low dose of 104
TCID50 (n = 2, closed symbols).

antibody production also showed an increase in concentration
that peaked at around one week post-ZIKV PR infection
(Figure 3D), whereas perforin levels followed a similar proﬁle
but with a smaller change of concentration (Figure 3F). None of
these systemic changes observed after primary ZIKV PR
infection were detected after challenge with ZIKV UG
(Supplemental Figure 2). Combined with the observation of
undetectable viremia, this suggests that the viral antigen load
generated after ZIKV UG challenge was insufﬁcient to elicit
detectable cytokine release.

antibody pairs validated for baboon molecules (Giavedoni et al.,
2004; Giavedoni, 2005; Hardy et al., 2009; Scordo et al., 2021;
Singh et al., 2021) (Figure 3). The two baboons that were
inoculated with 106 TCID50 of ZIKV PR had detectable peaks
of IFN-a by 1 day post-infection (dpi), whereas the animals
receiving 104 TCID50 of ZIKV PR peaked by 6 dpi (Figure 3A).
A similar pattern of early and transient peaks was detected for
IFN-g (Figure 3B), and the IFN-g-related cytokines IP-10
(Figure 3C) and MIG (Figure 3E). The tumor necrosis factor
ligand family member BAFF, involved in B-cell activation and
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ELISA and plaque-reduction neutralization (PRNT) tests
(Figure 4). ELISA assays identiﬁed the induction of baboon
antibodies that bound to ZIKV nonstructural protein 1 (NS1,
Figure 4A) or cross-reacted with Dengue virus envelope
glycoprotein (Figure 4B). In general, there was no difference in
magnitude of the antibody response in relation to the ZIKV
challenge dose; in fact, baboon 32569, which was inoculated with
104 TCID50 of ZIKV PR, developed a very rapid antibody
response that peaked by 2 weeks post-infection. A similar
pattern of response was observed for the generation of
neutralizing antibodies in the infected baboons, with baboon
32569 having a signiﬁcantly higher titer than the other 3 animals
(Figure 4C). After challenge with ZIKV UG, anti-ZIKV NS1 and
neutralizing antibodies signiﬁcantly increased in titers, whereas
cross-reacting anti-DV Env antibodies had a transient uptick in
responses by one week-post challenge. These anamnestic
antibody responses suggest that some level of viral replication,
below the limit of detection of the real time RT-PCR assay,
occurred and stimulated antibody production.
The anti-ZIKV cell-mediated immune response was
evaluated with an antigen-induced marker (AIM) assay that
interrogated both the production of certain cytokines as well as
the upregulation of cell surface markers on baboon cells exposed
to ZIKV viral-like particles; assays were performed before and
after challenge with ZIKV UG (Figure 5). Analysis of cytokines
produced by ZIKV-stimulated baboon PBMC showed that
expression of IL-6 was signiﬁcant before challenge with ZIKV
UG, almost after 6 months post-infection with ZIKV PR, and did
not change signiﬁcantly immediately after challenge with ZIKV
UG (Figure 5A). Interestingly, expression of Perforin after ZIKV
stimulation was only signiﬁcantly different after challenge with
ZIKV UG (Figure 5B), and this augmentation in cytokine
production after challenge was also observed for TNF-a
(Figure 5C). When analyzing upregulation of CD83 on B-cells
in response to ZIKV stimulation, we observed a signiﬁcant
antigen-driven response, but responses of these baboon cells
obtained before and after ZIKV UG challenge were of similar
magnitude (Figure 5D). Data from this AIM assay demonstrate
that primary ZIKV PR infection induces immunological memory
in baboons that lasts at least 6 months, and that may become
stimulated after re-exposure to the virus.

Analysis of the Anti-ZIKV
Immune Response
The analysis of the anti-ZIKV humoral responses in baboons
after primary infection and challenge was performed by both

A

B

C

Transcriptomic Analysis
We analyzed changes in the baboon PBMC transcription levels
by RNAseq and differential expression analysis. We extracted
PBMC RNA from the four baboons before infection with ZIKV
PR (day 0), and on days 3 and 15 post-infection, which
corresponded to the acute phase (day 3) and after resolution of
infection (day 15). The average sequencing depth was 3.07
million reads per sample ( ± 1.04 M reads). Principal
component analysis (PCA) plots indicated that one of the four
animals (32535) was an outlier at day 0 post-infection
(Supplemental Figure 1A). A second PCA plot was generated
excluding data from animal 32535 at day 0 and indicated that
animal 32535 was also an outlier at the other two timepoints
included in the RNA-seq data (days 3 and 15 post-infection)
(Supplemental Figure 1B). Due to these results, all data from

FIGURE 4 | Humoral immune responses to ZIKV in exposed baboons. (A)
ELISA anti-ZIKV NS1 IgG levels. (B) ELISA cross-reactive anti-Dengue virus
GP IgG antibodies. (C) Plaque-reduction neutralization test (PRNT) on
longitudinally collected baboon plasma. Baboons were challenged with the
virus in either a high dose of 106 TCID50 (n = 2, open symbols) or a low dose
of 104 TCID50 (n = 2, closed symbols).
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A
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C

D

FIGURE 5 | ZIKV-speciﬁc AIM assay. Baboon PBMCs were obtained a week before and a week after challenge with ZIKV UG, and were incubated with
supernatant of HEK cells transduced with empty lentiviral vector (RPMI), or with supernatant of HEK cells transduced with a lentiviral vector expressing ZIKVprME
protein (prME); Staphylococcus enterotoxin A and B (SEA/B) was used as positive control. After 24 hr stimulation supernatants were collected and used to measure
(A) IL-6, (B) Perforin, (C) TNF-a with a Luminex assay. (D) Cells were used to measure CD83 expression on CD20 B cells. Two-tailed paired t-test. ns, not
signiﬁcant (p>0.05), * = p< 0.05; ** = p<0.01; *** = p<0.001.

enriched gene sets for the day 3 vs 0 and 15 vs 3 comparisons
(Figure 7). Both the IFN alpha response and IFN gamma response
hallmark gene sets had a positive normalized enrichment score
(NES) for the day 3 vs 0 comparison (NES ≥ 2.4), and a negative
NES for the day 15 vs 3 comparison (NES ≤ -2.3) (Figure 7). The
Reactome “antiviral mechanism by IFN stimulated genes” gene set
and hallmark “interferon alpha response” and “interferon gamma
response” gene sets share several of the same highly signiﬁcant
DEGs, including IFIT1, IFIT3, ISG15, MX1, OAS1, and OASL,
which are signiﬁcantly upregulated (FDR ≤ 0.05 and LFC ≥ 1.0) at
day 3 vs 0 and signiﬁcantly downregulated (FDR ≤ 0.05 and LFC ≤
-1.0) at day 15 vs 3 (Supplemental Figures 4–6).
DAVID GO analyses detected one signiﬁcantly enriched GO
term (GO:0045071, “negative regulation of viral genome
replication”) associated with both the day 3 vs 0 and 15 vs 3
comparisons, and two additional GO terms that were
signiﬁcantly enriched for only the day 3 vs 0 comparison
(GO:0009615, “response to virus” and GO:0006955, “immune

animal 32535 were excluded from downstream analyses.
Differential expression analyses detected 27 upregulated (FDR
≤ 0.05 and LFC ≥ 1.0) and 20 downregulated (FDR ≤ 0.05 and
LFC ≤ -1.0) genes at day 3 vs 0, 276 upregulated and 153
downregulated genes at day 15 vs 3, and 16 upregulated and 2
downregulated genes at day 15 vs 0 (Supplemental Figure 3).
GSEA of Reactome canonical pathway gene sets found several
signiﬁcantly enriched gene sets for the day 3 vs 0 and 15 vs 3
comparisons, while no signiﬁcantly enriched gene sets were
detected for the day 15 vs 0 comparison (Figure 6). Among the
most signiﬁcantly enriched gene sets were “interferon alpha beta
signaling,” “interferon signaling,” and “antiviral mechanism by IFN
stimulated genes,” all of which had a positive normalized
enrichment score (NES) for the day 3 vs 0 comparison (NES ≥
2.21), and a negative NES for the day 15 vs 3 comparison (NES ≤
-1.95) (Figure 6). GSEA of hallmark gene sets produced similar
results, with the gene sets “interferon alpha response” and
“interferon gamma response” being two of the most signiﬁcantly
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FIGURE 6 | Gene Set Enrichment Analysis (GSEA) of Reactome canonical pathways. Gene sets revealed a pattern of increased expression of genes associated
with interferon signaling and antiviral mechanisms between the beginning and peak of infection (day 3 vs 0), then decreased expression of these genes between the
peak and resolution of infection (day 15 vs 3). No ﬁgure was included for the day 15 vs 0 comparison because no gene sets were signiﬁcantly enriched. (NES:
Normalized Enrichment Score).

conﬁrms the early detection of systemic interferon
production presented in Figure 3 and demonstrate to be a
very sensitive technique for identifying changes associated
with a transient, short-lived innate antiviral response to a
subclinical ZIKV infection.

response”). Heatmaps generated from the LFC values of DEGs
associated with these terms indicate that these DEGs tend to
be signiﬁcantly upregulated (FDR ≤ 0.05 and LFC ≥ 1.0) at day
3 vs 0 and signiﬁcantly downregulated (FDR ≤ 0.05 and LFC ≤
-1.0) at day 15 vs 3 (Figure 8). The transcriptomic data
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FIGURE 7 | Gene Set Enrichment Analysis (GSEA) of Hallmark gene sets. Revealed a pattern of increased expression of genes associated with the interferon alpha
and gamma response between the beginning and peak of infection (day 3 vs 0), then decreased expression of these genes between the peak and resolution of
infection (day 15 vs 3). (NES: Normalized Enrichment Score).

Whereas some baboon studies have seen clinical signs of
ZIKV infection (Gurung et al., 2018; Gurung et al., 2019;
Peregrine et al., 2019), we have seen an outcome similar to the
more than 80% of human cases, with ZIKV infection resulting in
a subclinical asymptomatic infection (Fauci and Morens, 2016;
Jimenez et al., 2017; Haby et al., 2018). This different outcome
between our studies and other baboon ZIKV studies may be
explained by the use of a different infecting doses [104-6 TCID50
in this study vs 106 FFU in other studies (Gurung et al., 2018;
Peregrine et al., 2019; Gurung et al., 2020)], differences in the
infecting ZIKV strain [ZIKV Puerto Rico isolate in our case vs
French Polynesia (Gurung et al., 2018; Peregrine et al., 2019)], or
the sex and age of baboons [juvenile males in our study vs adult
male or females (Gurung et al., 2018; Gurung et al., 2019;
Peregrine et al., 2019)]. As for the effect of ZIKV infectious
dose, we observed that the 106 TCID50 infecting dose resulted in
viremia in as short a time as 24 hr and early interferon response,

DISCUSSION
The baboon represents a NHP that has been frequently
employed in biomedical research of viral diseases (Locher
et al., 2003; Perry et al., 2012; Welliver et al., 2020; Singh et al.,
2021). The baboon may also represent one of the sylvatic
reservoirs of ZIKV, considering the baboon’s wide distribution
throughout Africa and serological evidence of baboon ZIKV
infection in the wild (Buechler et al., 2017). Consequently, the
baboon has been recently explored as a NHP model for
experimental ZIKV infection and pathogenesis (Gurung et al., 2018;
Gurung et al., 2019; Peregrine et al., 2019; Gurung et al., 2020).
In this study, we sought to increase validation of the baboon model
of ZIKV infection by employing molecular techniques and high
dimensional immunological analyses that have not been explored in
published studies and that are frequently used in human clinical work
or with other NHP species.
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studies would be needed to explain this phenomenon. The
baboon pattern of early and transient systemic cytokine
expression has also been seen in macaque models of ZIKV
infection (Hirsch et al., 2017; Pantoja et al., 2017).
Transcriptomic proﬁling of the baboon response to ZIKV
infection revealed upregulation of genes associated with IFN
alpha, beta, and gamma signaling and antiviral responses
between days 0 and 3, then downregulation of the same sets of
genes between days 3 and 15, a period when viral infection was
effectively controlled. The upregulation of genes related to IFN
signaling early in infection has been observed in other studies of
ZIKV infection in whole blood of rhesus and cynomolgus
macaques (Schouest et al., 2020), as well as in human PBMCs
in vitro (Lim et al., 2020). Several genes found to be upregulated
in both the Lim 2020 and Schouest 2020 studies were also
upregulated (FDR ≤ 0.05 and LFC ≥ 1.0) in our results,
including IFI44, IFIT1, IFIT3, MX1, OAS1, and OASL
(Supplemental Figures 4–6). Finally, this study demonstrated
that subclinical ZIKV infection can induce a protective immune
response against re-exposure with an evolutionary distant ZIKV
isolate, and that re-exposure to ZIKV induces an anamnestic
immune response to the virus, even in the absence of detectable
viremia, a ﬁnding that has also been reported in rhesus macaque
models of ZIKV infection (Osuna et al., 2016; Schouest et al.,
2020; Schouest et al., 2021).
The low number of replicates (n = 4 for immunological
assays and n = 3 for RNA-seq) may lead to reduced statistical
power and an increased margin of error, however, low numbers
of replicates are relatively common among NHP studies due to
economic and ethical considerations. Some ZIKV studies
utilizing NHP models have been performed on cohorts of as
few as 2 animals (Koide et al., 2016; Hirsch et al., 2017). Despite
the limitation of sample size, NHP models are crucial to
translational research, especially in the case of studying
viruses such as ZIKV that do not naturally replicate in the
cells of other commonly used model organisms, such as rodents
(Nazerai et al., 2019).
In summary, the results of the molecular and omic techniques
presented in this manuscript are similar to what has been learned
with other macaque models of ZIKV infection and from human
cases, and therefore validate these techniques when applied to
the baboon ZIKV model. The baboon model of ZIKV infection
offers a valid alternative to the macaque model and could
alleviate the nationwide shortage of macaques available for
biomedical research, which has been dramatically strained by
the extensive use of macaques for COVID-19 studies (Chang
et al., 2021). Besides availability, the baboon as an animal model
stands on its own for studies on eclampsia (Carter, 2007),
placentation (Carter, 2007), endometriosis (Kyama et al.,
2007), neonatal development (Giavedoni et al., 2004; Warfel
et al., 2014; Kuo et al., 2017), and maternal nutrition and
offspring health (Li et al., 2017; Light et al., 2018). All these
areas of study are still relevant for unresolved issues associated
with ZIKV and complications with infection, and the molecular
tools presented in this manuscript can contribute to
their understanding.

A

B

C

FIGURE 8 | Heat maps of genes associated with the gene ontology (GO)
terms. (A) “negative regulation of viral genome replication,” (B) “response to
virus,” and (C) “immune response”. The three GO terms shown here were the
only ones found to be signiﬁcantly enriched by the DAVID Functional
Annotation tool. No GO terms were found to be enriched for the day 15 vs 0
comparison. Boxes with an X indicates an FDR > 0.05.

but the duration and resolution of infection and immune
response of the animals were not different from the outcome
observed for animals receiving 104 TCID50.
The ﬂow cytometry and cytokine analyses of baboon blood
after ZIKV infection showed the expected early activation of the
innate immune response, which in turn resulted in activation of
cells of the adaptive immune system. An interesting observation
was the transient peak of expression of CD154 on CD4 T cells,
considering that expression of CD154 is tightly regulated and
occurs after T cell receptor engagement with an antigenpresenting cell; it is highly unlikely that all these CD4 T cells
expressing CD154 were speciﬁc for ZIKV antigens, which could
suggest some bystander activation of CD4 T cells, but additional
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